NCT05359861 2026-03-18
Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma
Coherus Oncology, Inc.
Phase 2 Completed
Clinical Trials
3,493 trialsNCT06108479 2026-03-18
Study of DF6215 in Patients With Advanced Solid Tumors
Dragonfly Therapeutics
Phase 1 Completed
NCT06298357 2026-03-18
Virtual Reality Gaming for Exercise and Mindfulness Among Pediatric Cancer Rehabilitation
University of Alabama at Birmingham
Phase 1 Completed
NCT02467270 2026-03-17
OPTIC
Takeda
Phase 2 Completed
NCT00420563 2026-03-16
PAL-ANGI
Centre Oscar Lambret
Phase 2 Completed
NCT01721343 2026-03-16
Collaborative Targeted Case Management in Improving Functional Status in Patients With Stage III-IV Cancer
Mayo Clinic
Phase NA Completed
NCT06072833 2026-03-16
Characterizing and Addressing Financial Toxicity in AYAs With Cancer
Columbia University
Phase NA Completed
NCT00580515 2026-03-13
Trial of Family Focused Grief Therapy in Palliative Care and Bereavement
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT01046487 2026-03-13
PALANGI3
Centre Oscar Lambret
Phase 1 Completed
NCT01247779 2026-03-13
ROBO-GYN
Centre Oscar Lambret
Phase NA Completed
NCT01596816 2026-03-13
CKNO-PRO
Centre Oscar Lambret
Phase 2 Completed
NCT01804712 2026-03-12
Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical Prostatectomy
University of California, San Diego
Phase EARLY_PHASE1 Completed
NCT04332653 2026-03-09
NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
NeoImmuneTech
Phase 1/2 Completed
NCT02423057 2026-03-06
Phase I Trial of 4'-Thio-2'-Deoxycytidine (TdCyd) in Patients With Advanced Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT02840058 2026-03-06
ITHER
Centre Hospitalier Universitaire de Besancon
Phase NA Completed
NCT03259763 2026-03-06
EUS-GE vs ES for Palliation of Gastric Outlet Obstruction
Johns Hopkins University
Phase NA Completed
NCT06048822 2026-03-06
Enhancing Cancer Survivorship With Pickleball
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Completed
NCT06248450 2026-03-06
YouCanPrefer
Linkoeping University
Phase NA Completed
NCT06340815 2026-03-06
Varian ProBeam Proton Therapy System Clinical Trial (Shandong)
Varian, a Siemens Healthineers Company
Phase NA Completed
NCT07450833 2026-03-05
BOOST
Benfovir AG
Phase 1 Completed
NCT07445243 2026-03-03
Integrated Chinese and Western Therapy for Cancer-Related Fatigue
Taichung Tzu Chi Hospital
Phase NA Completed
NCT05148078 2026-03-02
Pediatric Radiation Oncology With Movie Induced Sedation Effect (PROMISE)
University of Texas Southwestern Medical Center
Phase 2 Completed
NCT01602380 2026-02-27
FALCON
AstraZeneca
Phase 3 Completed
NCT01909453 2026-02-27
COLUMBUS
Pfizer
Phase 3 Completed
NCT03060096 2026-02-27
Telehealth
Wake Forest University Health Sciences
Phase NA Completed
NCT04568278 2026-02-27
Mobile Application Using the PRO-CTCAE to Improve Patients' Participation in Symptom Management During Treatment.
Samsung Medical Center
Phase NA Completed
NCT05358951 2026-02-27
Sleep Treatment Education Program for Young Adult Cancer Survivors (STEP-YA)
Dana-Farber Cancer Institute
Phase NA Completed
NCT05377554 2026-02-27
Bevonescein for Intra-Operative Nerve Visualization in Head and Neck Surgery
Alume Biosciences, Inc.
Phase 3 Completed
NCT06056791 2026-02-27
CaRe
Inmune Bio, Inc.
Phase 1/2 Completed
NCT05051735 2026-02-25
PARASTOP
Oslo University Hospital
Phase 3 Completed
NCT02705196 2026-02-24
LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer
Lokon Pharma AB
Phase 1/2 Completed
NCT03400332 2026-02-24
A Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced Cancers
Bristol-Myers Squibb
Phase 1/2 Completed
NCT03466957 2026-02-20
Individual Approach in Gynecological Cancer Brachytherapy
Institute of Oncology Ljubljana
Phase NA Completed
NCT04461509 2026-02-20
High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy
Cedars-Sinai Medical Center
Phase 2 Completed
NCT03445858 2026-02-18
Pembrolizumab in Combination With Decitabine and Hypofractionated Index Lesion Radiation in Pediatrics and Young Adults
Children's Hospital Medical Center, Cincinnati
Phase EARLY_PHASE1 Completed
NCT03964233 2026-02-18
A Study in Patients With Different Types of Advanced Cancer (Solid Tumors) to Test Different Doses of BI 907828 (Brigimadlin) in Combination With BI 754091 (Ezabenlimab) and BI 754111 or BI 907828 (Brigimadlin) in Combination With BI 754091 (Ezabenlimab)
Boehringer Ingelheim
Phase 1 Completed
NCT05804032 2026-02-18
Lenalidomide, Bortezomib and Dexamethasone Induction Therapy With Either Intravenous or Subcutaneous Isatuximab in Patients With Newly Diagnosed Multiple Myeloma
University of Heidelberg Medical Center
Phase 3 Completed
NCT04397276 2026-02-17
A Study of JNJ-70218902 in Participants With Advanced Stage Solid Tumors
Janssen Research & Development, LLC
Phase 1 Completed
NCT06758011 2026-02-17
ivWatch in Prevention of Extravasation of Vesicants in an Oncology Setting
Roswell Park Cancer Institute
Phase NA Completed
NCT07415629 2026-02-17
Evaluation of a Self-compassion App in People With Cancer: Feasibility, Acceptability and Changes in Well-being
University Medical Center Groningen
Phase NA Completed
NCT03388190 2026-02-13
METIMMOX
University Hospital, Akershus
Phase 2 Completed
NCT05490641 2026-02-13
Project KNOWN
The University of Texas at Arlington
Phase NA Completed
NCT05829824 2026-02-13
Tobacco Cessation Care for Cancer Patients by Automated Interactive Outreach
University of California, San Francisco
Phase NA Completed
NCT06686823 2026-02-13
Effects of a Cognitive Training Program on Chemotherapy-induced Cognitive Impairment (Chemobrain) in Breast Cancer Patients Undergoing Active Treatment
University of Salamanca
Phase NA Completed
NCT03993353 2026-02-12
Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
University of California, San Diego
Phase 2 Completed
NCT02212860 2026-02-11
SIGNAL 2
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase NA Completed
NCT01534598 2026-02-10
FdCyd and THU for Advanced Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT04455698 2026-02-10
ENGAGE
University of Chicago
Phase NA Completed
NCT04966520 2026-02-10
Accelerated Neuromodulation to Alleviate Cognitive Deficits Due to Cancer Therapy
University of Iowa
Phase NA Completed
NCT03674138 2026-02-06
Pharmacogenomic-Guided Antidepressant Drug Prescribing in Cancer Patients
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Completed